Cargando…
Emerging Therapeutic RNAs for the Targeting of Cancer Associated Fibroblasts
Tumor mass consists of a complex ensemble of malignant cancer cells and a wide variety of resident and infiltrating cells, secreted factors, and extracellular matrix proteins that are referred as tumor microenvironment (TME). Cancer associated fibroblasts (CAFs) are key TME components that support t...
Autores principales: | Santana-Viera, Laura, Ibba, Maria L., Rotoli, Deborah, Catuogno, Silvia, Esposito, Carla L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352655/ https://www.ncbi.nlm.nih.gov/pubmed/32466591 http://dx.doi.org/10.3390/cancers12061365 |
Ejemplares similares
-
Advances in Oligonucleotide Aptamers for NSCLC Targeting
por: Rotoli, Deborah, et al.
Publicado: (2020) -
The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses
por: Ciccone, Giuseppe, et al.
Publicado: (2023) -
Coupling Aptamers to Short Interfering RNAs as Therapeutics
por: Cerchia, Laura, et al.
Publicado: (2011) -
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
por: Esposito, Carla Lucia, et al.
Publicado: (2021)